Pieter A. Doevendans

43.0k total citations · 7 hit papers
652 papers, 27.4k citations indexed

About

Pieter A. Doevendans is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Pieter A. Doevendans has authored 652 papers receiving a total of 27.4k indexed citations (citations by other indexed papers that have themselves been cited), including 399 papers in Cardiology and Cardiovascular Medicine, 185 papers in Surgery and 140 papers in Molecular Biology. Recurrent topics in Pieter A. Doevendans's work include Cardiac Imaging and Diagnostics (91 papers), Cardiac electrophysiology and arrhythmias (81 papers) and Cardiac Arrhythmias and Treatments (67 papers). Pieter A. Doevendans is often cited by papers focused on Cardiac Imaging and Diagnostics (91 papers), Cardiac electrophysiology and arrhythmias (81 papers) and Cardiac Arrhythmias and Treatments (67 papers). Pieter A. Doevendans collaborates with scholars based in Netherlands, Germany and United States. Pieter A. Doevendans's co-authors include Joost P. G. Sluijter, Maarten J. Cramer, Gerard Pasterkamp, Sander S. Rensen, Guillaume J.J.M. van Eys, Fatih Arslan, Leo Timmers, Steven A. J. Chamuleau, Arco J. Teske and Imo E. Hoefer and has published in prestigious journals such as Nature, The Lancet and Advanced Materials.

In The Last Decade

Pieter A. Doevendans

626 papers receiving 26.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury

2013 908 citations Fatih Arslan, Mirjam B. Smeets et al. Stem Cell Research profile →
Diagnostic Accuracy of 64-Slice Computed Tomography Coronary Angiography

2008 838 citations J. Wouter Jukema, Pieter A. Doevendans et al. profile →
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes

2003 789 citations Christine L. Mummery, Dorien Ward‐van Oostwaard et al. Circulation profile →
MicroRNAs in the Human Heart

2007 730 citations Linda W. van Laake, Pieter A. Doevendans et al. Circulation profile →
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity

2007 680 citations Sander S. Rensen, Pieter A. Doevendans et al. Netherlands Heart Journal profile →
Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study

2011 392 citations Pieter A. Doevendans et al. profile →
A prospective validation of the HEART score for chest pain patients at the emergency department

2013 371 citations Maarten J. Cramer, Pieter A. Doevendans et al. International Journal of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pieter A. Doevendans Netherlands	81	13.6k	9.7k	6.4k	3.6k	3.1k	652	27.4k
Junbo Ge China	70	7.7k 0.6×	5.8k 0.6×	6.1k 0.9×	2.5k 0.7×	1.7k 0.5×	843	19.2k
Gerard Pasterkamp Netherlands	78	6.6k 0.5×	9.0k 0.9×	6.4k 1.0×	2.6k 0.7×	4.6k 1.5×	515	24.8k
Nikolaos G. Frangogiannis United States	88	17.7k 1.3×	13.6k 1.4×	6.9k 1.1×	1.2k 0.3×	3.0k 1.0×	178	30.9k
Elena Aïkawa United States	78	7.4k 0.5×	6.5k 0.7×	4.6k 0.7×	2.4k 0.7×	2.4k 0.8×	261	22.1k
Issei Komuro Japan	103	16.8k 1.2×	20.5k 2.1×	6.8k 1.1×	1.7k 0.5×	2.7k 0.9×	1.2k	42.9k
Douglas L. Mann United States	95	23.1k 1.7×	11.7k 1.2×	6.8k 1.1×	1.8k 0.5×	2.4k 0.8×	452	39.3k
Joshua M. Hare United States	95	12.7k 0.9×	11.3k 1.2×	10.5k 1.6×	1.7k 0.5×	1.7k 0.6×	386	32.9k
Christopher Heeschen Germany	73	4.7k 0.3×	10.1k 1.0×	4.9k 0.8×	1.9k 0.5×	4.0k 1.3×	167	22.7k
Toyoaki Murohara Japan	88	14.1k 1.0×	18.0k 1.9×	11.1k 1.7×	2.6k 0.7×	4.3k 1.4×	1.2k	45.3k
Lina Badimón Spain	86	13.8k 1.0×	7.8k 0.8×	11.7k 1.8×	3.5k 1.0×	3.9k 1.3×	700	35.1k

Countries citing papers authored by Pieter A. Doevendans

Since Specialization

Citations

This map shows the geographic impact of Pieter A. Doevendans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter A. Doevendans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter A. Doevendans more than expected).

Fields of papers citing papers by Pieter A. Doevendans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter A. Doevendans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter A. Doevendans. The network helps show where Pieter A. Doevendans may publish in the future.

Co-authorship network of co-authors of Pieter A. Doevendans

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter A. Doevendans. A scholar is included among the top collaborators of Pieter A. Doevendans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter A. Doevendans. Pieter A. Doevendans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maas, Renée G. C., et al.. (2025). Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive Overview. Circulation Heart Failure. 18(12). e012661–e012661.

Cramer, Maarten J., et al.. (2024). Generation and characterization of novel induced pluripotent stem cell (iPSC) lines derived from three symptomatic carriers of a pathogenic MYH11 variant and two non-carrier relatives. Stem Cell Research. 82. 103630–103630.

Tuijl, Sjoerd van, et al.. (2024). Extended Normothermic Ex Situ Heart Perfusion without Functional Decline. The Journal of Heart and Lung Transplantation. 43(4). S156–S156. 1 indexed citations

Henkens, Michiel T.H.M., Anneline S.J.M. te Riele, Arjan C. Houweling, et al.. (2022). The Netherlands Heart Tissue Bank. Netherlands Heart Journal. 31(1). 16–20. 4 indexed citations

Spee, Ruud F., Anton E. Tuinenburg, Patrick Houthuizen, et al.. (2019). High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial. International Journal of Cardiology. 299. 169–174. 11 indexed citations

Linschoten, Marijke, Maarten J. Cramer, Eelke Gort, et al.. (2019). Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics. JACC CardioOncology. 1(2). 280–290. 21 indexed citations

Mol, Emma A., Zhiyong Lei, Marieke T. Roefs, et al.. (2019). Injectable Supramolecular Ureidopyrimidinone Hydrogels Provide Sustained Release of Extracellular Vesicle Therapeutics. Advanced Healthcare Materials. 8(20). e1900847–e1900847. 82 indexed citations

Waes, Judith A. R. van, Hendrik M. Nathoe, Jurgen C. de Graaff, et al.. (2013). Myocardial Injury After Noncardiac Surgery and its Association With Short-Term Mortality. Circulation. 127(23). 2264–2271. 214 indexed citations

Groeneweg, Judith A., Paul A. van der Zwaag, Louise R.A. Olde Nordkamp, et al.. (2013). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers. The American Journal of Cardiology. 112(8). 1197–1206. 39 indexed citations

10.

Verloop, Willemien L., Eva E. Vink, Michiel Voskuil, et al.. (2013). Eligibility for percutaneous renal denervation. Journal of Hypertension. 31(8). 1662–1668. 32 indexed citations

11.

Gho, Johannes M.I.H., Stefan Koudstaal, Sanne J. Jansen of Lorkeers, et al.. (2013). Cell Therapy, a Novel Remedy for Dilated Cardiomyopathy? A Systematic Review. Journal of Cardiac Failure. 19(7). 494–502. 21 indexed citations

12.

Laake, Linda W. van, Robert Passier, Krista den Ouden, et al.. (2010). Human embryonic stem cell-derived cardiomyocytes improve cardiac function after myocardial infarction : paracrine effects outweigh the contribution of active contractile force. European Heart Journal. 31. 79–79. 1 indexed citations

13.

Stella, Pieter R., Piergiuseppe Agostoni, Hendrik M. Nathoe, et al.. (2010). One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Netherlands Heart Journal. 18(10). 486–492. 1 indexed citations

14.

Arslan, Fatih, Mirjam B. Smeets, Luke O'neill, et al.. (2009). Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody. Circulation. 121(1). 80–90. 279 indexed citations

15.

Rensen, Sander S., Petra Niessen, Jan M. van Deursen, et al.. (2008). Smoothelin-B Deficiency Results in Reduced Arterial Contractility, Hypertension, and Cardiac Hypertrophy in Mice. Circulation. 118(8). 828–836. 38 indexed citations

16.

Bongartz, Lennart G., Branko Braam, Marianne C. Verhaar, et al.. (2008). Abstract 1490: The Nitric Oxide (NO) Donor Molsidomine Rescues Heart Function in Experimental Cardiorenal Failure. Circulation. 118. 1 indexed citations

17.

Stella, Pieter R., et al.. (2008). Safety and efficacy of drug‐eluting balloons in percutaneous treatment of bifurcation lesions the DEBIUT (drug‐eluting balloon in bifurcaton utrecht) registry. Catheterization and Cardiovascular Interventions. 71(5). 629–635. 67 indexed citations

18.

Rensen, Sander S., Pieter A. Doevendans, & Guillaume J.J.M. van Eys. (2007). Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Netherlands Heart Journal. 15(3). 100–108. 680 indexed citations breakdown →

19.

Doevendans, Pieter A., et al.. (2005). The Influence of Oestrogen-Deficiency and ACE Inhibition on the Progression of Myocardial Hypertrophy in Spontaneously Hypertensive Rats. European Journal of Heart Failure. 7(7). 1079–1084. 15 indexed citations

20.

Doevendans, Pieter A.. (2001). Unravelling the pathophysiology of heart failure through human genomics. European Journal of Clinical Investigation. 31(5). 378–379. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact